GSK pro­motes rou­tine im­mu­niza­tions for adults amid post-pan­dem­ic vac­cine back­slide

GSK launched a new ini­tia­tive on Thurs­day and com­mit­ted up to $1 mil­lion in grant fund­ing to im­prove adult rou­tine vac­ci­na­tion rates.

While the pan­dem­ic spot­light was trained on the race for nov­el Covid-19 vac­cines, oth­er rou­tine vac­ci­na­tion rates plum­met­ed, rais­ing con­cerns that missed dos­es may put chil­dren and even some adults at risk of pre­ventable dis­eases such as measles or shin­gles. The World Health Or­ga­ni­za­tion last year re­port­ed the largest drop in child­hood vac­ci­na­tions in rough­ly three decades.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER